Connect with us

Company News

The Cigna Group announces pricing terms of tender offers

The Cigna Group announced the pricing terms of its previously announced offers to purchase for cash any and all of The Cigna Group’s 3.50% Senior Notes due 2024 and Evernorth Health, Inc.’s 3.50% Senior Notes due 2024 and up to $1,550,000,000 aggregate principal amount of the Company’s 4.125% Senior Notes due 2025, the Company’s 4.500% Senior Notes due 2026, Evernorth’s 4.500% Senior Notes due 2026, the Company’s 1.250% Senior Notes due 2026, the Company’s 3.050% Senior Notes due 2027, Cigna Holding Company’s 3.050% Senior Notes due 2027 and the Company’s 2.400% Senior Notes due 2030, in each case, validly tendered and accepted by the Company, upon the terms and subject to the conditions set forth in the Offer to Purchase dated February 5, 2024 and as amended by the press release dated the date hereof announcing the early results of the Tender Offers and the upsize of the Maximum Tender Offer. The Any and All Notes and the Maximum Tender Offer Notes are referred to collectively as the “Securities” and the Any and All Tender Offer and the Maximum Tender Offer are referred to collectively as the “Tender Offers.”

The “Total Consideration” payable per $1,000 principal amount of each series of Securities validly tendered and accepted for purchase was determined by the Dealer Managersbased on a spread over a reference U.S. Treasury Security, as set forth in the tables below, in accordance with standard market practice as of 10:00 a.m., New York City time, on February 20, 2024 and, as set forth in the tables below, includes an Early Tender Payment of $30. As previously announced, the Company does not expect to accept any of the Company’s 3.050% Senior Notes due 2027 or Cigna Holding Company’s 3.050% Senior Notes due 2027. Any and All Notes validly tendered and not validly withdrawn will be accepted as set forth in the Offer to Purchase until the Expiration Date.

The following table summarizes the material pricing terms for the Tender Offers:

Any and all tender offer

Title of Security CUSIP
Numbers
Fixed
Spread
(bps)
Reference
U.S. Treasury
Security
Reference
Yield
Total
Consideration
(a)(b)
The
Cigna
Group’s
3.50%
Senior
Notes
due
2024
125523BX7;

125523BW9;
U1716AAT4

20 0.250%
U.S.
Treasury
Notes
due
June 15,
2024
5.406 % $993.39
Evernorth
Health,
Inc.’s
3.50%
Senior
Notes
due
2024
30219GAK4 20 0.250%
U.S.
Treasury
Notes
due
June 15,
2024
5.406 % $993.39

Maximum tender offer

Title of
Security
CUSIP
Numbers
Acceptance
Priority
Level
(a)
Fixed
Spread
(bps)
Reference
U.S.
Treasury
Security
Reference
Yield
Total
Consideration
(b)(c)
The
Cigna
Group’s
4.125%
Senior
Notes
due
2025
125523AG5;
40573LAQ9;U4058LAH6
1 45 4.250%
U.S.
Treasury
Notes
due
January
31, 2026
4.584 % $985.05
The
Cigna
Group’s
4.500%
Senior
Notes
due
2026
125523BZ2;

125523BY5;

U1716AAU1

2 45 4.250%
U.S.
Treasury
Notes
due
January
31, 2026
4.584 % $989.92
Evernorth
Health,
Inc.’s
4.500%
Senior
Notes
due
2026
30219GAM0 2 45 4.250%
U.S.
Treasury
Notes
due
January
31, 2026
4.584 % $989.92
The
Cigna
Group’s
1.250%
Senior
Notes
due
2026
125523CP3 3 45 4.250%
U.S.
Treasury
Notes
due January
31, 2026
4.584 % $926.69
The
Cigna
Group’s
2.400%
Senior
Notes
due
2030
125523CL2 5 75 4.000%
U.S.
Treasury
Notes
due
January
31, 2029
4.231 % $866.32

As previously announced, it is anticipated that payment for the Securities that were validly tendered and accepted for purchase as of 5:00 p.m., New York City time, on February 16, 2024 (the “Early Tender Date”) will be made on February 22, 2024.

The Tender Offers will expire at 5:00 p.m., New York City Time, on March 5, 2024 (such time and date, as the same may be extended, the “Expiration Date”). As previously announced, because the Maximum Tender Offer has been fully subscribed as of the Early Tender Date, the Company does not expect to accept for purchase any Maximum Tender Offer Notes tendered by holders after the Early Tender Date. Any and All Notes validly tendered and not validly withdrawn will be accepted as set forth in the Offer to Purchase until the Expiration Date.
MB Bureau

Copyright © 2024 Medical Buyer

error: Content is protected !!